Oceania · Regional markets · The Motley Fool Australia

Do I still rate CSL shares as a buy after rising 120% in four months?

Published by The Motley Fool Australia · Australia 1 h ago

Let's see if it is too late to buy this biotech giant's shares. The post Do I still rate CSL shares as a buy after rising 120% in four months? appeared first on The Motley Fool…

Read the full article on The Motley Fool Australia Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.fool.com.au)

Also worth reading

SmartCompany

Do I still rate CSL shares as a buy after rising 120% in four months?

Share

Also worth reading

What David Jones can teach small business owners about letting go

Morning Headlines

The hidden risk of being the one who handles the money

Regional areas suffer from 'buyer's market with no buyers'

The AI bubble just burst. Here’s what it means for NZ – Liam Dann

ChartWatch ASX Scans: Wisetech Global, Pro Medicus, Domino's Pizza, Metcash, Neuren Pharmaceuticals, Temple & Webster